Inventors:
Mohan B. Kabadi - Marlboro NJ
Richard V. Vivilecchia - Rockaway NJ
International Classification:
A61K 31505, A61K 31435, A61K 3144, A61K 31405, A61K 3119
Abstract:
A pharmaceutical dosage form comprising an HMG-CoA reductase inhibitor compound, e. g. , fluvastatin sodium, is disclosed which is stabilized against pH-related degradation by an alkaline stabilizing medium capable of imparting a pH of at least 8 to an aqueous solution or dispersion of the composition.